Mechanism by which phosphonoformic acid resistance mutations restore 3′-azido-3′-deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase

被引:51
作者
Arion, D
Sluis-Cremer, N
Parniak, MA
机构
[1] Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, AIDS Ctr, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
关键词
D O I
10.1074/jbc.275.13.9251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of phosphonoformic acid (PFA) resistance against a background of 3'-azido-3'-deoxythymidine (AZT) resistance in human immunodeficiency virus type 1 (HIV-1) restores viral sensitivity to AZT, High level AZT resistance requires multiple mutations (D67N/K70R/T215F/K219Q). In order to characterize the mechanism of PFA resistance-mediated resensitization to AZT, the A114S mutation associated with PFA resistance was introduced into the reverse transcriptase (RT) of both wild type and drug-resistant virus. We previously showed that pyrophosphorolytic removal of chain-terminating AZT is the primary mechanism of the AZT resistance phenotype (Arion, D,, Kaushik, N,, McCormick, S., Borkow, G., and Parniak, M.A. (1998) Biochemistry 37, 15908-15917), Introduction of A114S into the AZT resistance background significantly diminishes both the enhanced pyrophosphorolytic activity and the DNA synthesis processivity associated with the AZT resistant RT, The A114S mutation also alters the nucleotide-dependent phosphorolysis activity associated with AZT resistance. The presence of the A114S mutation therefore severely impairs the mutant enzyme's ability to excise chain-terminating AZT, The decrease in phosphorolytic activity of RT conferred by the PFA resistance A114S mutation resensitizes AZT-resistant HIV-1 to AZT by allowing the latter to again function as a chain terminator of viral DNA synthesis. These data further underscore the importance of phosphorolytic removal of chain-terminating AZT as the primary mechanism of HIV-1 AZT resistance.
引用
收藏
页码:9251 / 9255
页数:5
相关论文
共 24 条
[1]   HIV resistance to zidovudine: the role of pyrophosphorolysis [J].
Arion, D ;
Parniak, MA .
DRUG RESISTANCE UPDATES, 1999, 2 (02) :91-95
[2]   The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase [J].
Arion, D ;
Borkow, G ;
Gu, ZG ;
Wainberg, MA ;
Parniak, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) :19860-19864
[3]   Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT):: Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase [J].
Arion, D ;
Kaushik, N ;
McCormick, S ;
Borkow, G ;
Parniak, MA .
BIOCHEMISTRY, 1998, 37 (45) :15908-15917
[4]  
ARTS EJ, 1994, J BIOL CHEM, V269, P14672
[5]   HIGH-LEVEL RESISTANCE TO (-) ENANTIOMERIC 2'-DEOXY-3'-THIACYTIDINE IN-VITRO IS DUE TO ONE AMINO-ACID SUBSTITUTION IN THE CATALYTIC SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
BOUCHER, CAB ;
CAMMACK, N ;
SCHIPPER, P ;
SCHUURMAN, R ;
ROUSE, P ;
WAINBERG, MA ;
CAMERON, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2231-2234
[6]   Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3′-azido-3′-deoxythymidine 5′-monophosphate-terminated primer [J].
Canard, B ;
Sarfati, SR ;
Richardson, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14596-14604
[7]   Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase [J].
Fletcher, RS ;
Holleschak, G ;
Nagy, E ;
Arion, D ;
Borkow, G ;
Gu, ZX ;
Wainberg, MA ;
Parniak, MA .
PROTEIN EXPRESSION AND PURIFICATION, 1996, 7 (01) :27-32
[8]   Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility [J].
Harrigan, PR ;
Kinghorn, I ;
Bloor, S ;
Kemp, SD ;
Najera, I ;
Kohli, A ;
Larder, BA .
JOURNAL OF VIROLOGY, 1996, 70 (09) :5930-5934
[9]   Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase [J].
Harris, D ;
Kaushik, N ;
Pandey, PK ;
Yadav, PNS ;
Pandey, VN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) :33624-33634
[10]   An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine [J].
Hooker, DJ ;
Tachedjian, G ;
Solomon, AE ;
Gurusinghe, AD ;
Land, S ;
Birch, C ;
Anderson, JL ;
Roy, BM ;
Arnold, E ;
Deacon, NJ .
JOURNAL OF VIROLOGY, 1996, 70 (11) :8010-8018